In addition to a possible candidate biomarker to predict future adverse events in patients with acute coronary syndromes (ASC) and myocardial infarction,35,36 MPO has been associated with the severity of CHF.4 In our study, the levels of MPO were elevated. This evidence concerns the gene MPO and Tako-tsubo cardiomyopathy.